Victory Capital Management Inc. lifted its holdings in Bruker Co. (NASDAQ:BRKR – Free Report) by 32.2% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 56,961 shares of the medical research company’s stock after purchasing an additional 13,888 shares during the period. Victory Capital Management Inc.’s holdings in Bruker were worth $3,549,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Farther Finance Advisors LLC grew its holdings in shares of Bruker by 90.4% in the second quarter. Farther Finance Advisors LLC now owns 356 shares of the medical research company’s stock valued at $26,000 after purchasing an additional 169 shares in the last quarter. Zions Bancorporation N.A. acquired a new position in Bruker during the 1st quarter worth approximately $26,000. Altshuler Shaham Ltd purchased a new stake in shares of Bruker in the 4th quarter valued at approximately $27,000. IFP Advisors Inc raised its holdings in shares of Bruker by 67.8% in the 2nd quarter. IFP Advisors Inc now owns 438 shares of the medical research company’s stock valued at $32,000 after purchasing an additional 177 shares in the last quarter. Finally, First Capital Advisors Group LLC. acquired a new position in shares of Bruker during the second quarter worth $33,000. Institutional investors and hedge funds own 79.78% of the company’s stock.
Bruker Stock Performance
Shares of Bruker stock opened at $70.95 on Friday. The firm has a market capitalization of $9.82 billion, a P/E ratio of 32.70, a P/E/G ratio of 2.41 and a beta of 1.14. Bruker Co. has a 52 week low of $53.79 and a 52 week high of $84.84. The company has a quick ratio of 1.04, a current ratio of 1.89 and a debt-to-equity ratio of 0.90. The firm’s 50 day moving average is $71.53 and its two-hundred day moving average is $66.11.
Bruker Dividend Announcement
Analysts Set New Price Targets
A number of analysts have weighed in on BRKR shares. Wolfe Research started coverage on Bruker in a research note on Wednesday, December 13th. They issued an “outperform” rating and a $80.00 price target on the stock. JPMorgan Chase & Co. cut their target price on Bruker from $70.00 to $65.00 and set a “neutral” rating on the stock in a research report on Tuesday, October 17th. Finally, Wells Fargo & Company started coverage on Bruker in a report on Tuesday, December 19th. They issued an “equal weight” rating and a $72.00 price target for the company. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $80.00.
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies.
- Five stocks we like better than Bruker
- Business Services Stocks Investing
- The 5 best small cap AI companies to buy now
- Comparing and Trading High PE Ratio Stocks
- Cirrus Logic: A chip stock you’re going to hear a lot more about
- With Risk Tolerance, One Size Does Not Fit All
- Archer Aviation’s sky-high progress and short interest
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.